Increasing Prevalence Of Cancer And Rise In Demand From The Asia Pacific Region Will Drive The Overall Immunotherapy Drugs Market


Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells (NK Cell), etc., work collectively to protect the body against cancer by aiming at abnormal antigens articulated on the facade of the tumor cells.Therapies including granulocyte colony-stimulating factor (G-CSF), imiquimod, interferons as well as parts of cellular membrane from bacteria are approved for medical use. Some of the others such as IL-7, IL-2, IL-12, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans anda variety of chemokines are involved in preclinical and clinical studies.

An increase in the prevalence of cancer and a number of autoimmune diseases, the demand for immunotherapy drugs is likely to increase. Moreover, with the rising need for mAbs, the immunotherapy drugs market is anticipated to have a positive outlook till the end of the forecast period 2016-2024. MAbs have a high affinity towards the specific disease cells as well as areas that require treatment. Accordingly, they can be utilized for therapies such asantibody-directed enzyme prodrug therapy and radio immunotherapy. The increaseduse of these antibodies in the drug development processis likely toaid to boost the market’s revenue making capacity over the forecast period.
Another important factor driving the growth prospects ofthe global immunotherapy drugs market is the materialization of biosimilars. Dissimilarto generic drugs that have active pharmaceutical ingredients alikeoriginal drugs, biosimilars are nearly identical to their creator biologic compounds. In view of the fact that biosimilars are less expensive and aid to make managementof diseases more reachable for the patients than biologics, the sale of biosimilars among the patients and hospitals alike is likely to riseconsiderably during the forecast period thereby augmenting the overall growth of the immunotherapy drugs market.
Immunotherapy Drugs Market Taxonomy
On the basis of product type,
  • Vaccines
  • mAbs
  • Non-specific immunotherapies
  • Immune checkpoint inhibitors
On the basis of therapy area,
  • Cancer
  • Autoimmune and Inflammatory Diseases
  • Infectious Diseases
  • Other Therapy Areas
Get Sample Copy Of This Exclusive Report: https://www.coherentmarketinsights.com/insight/request-sample/525

According to National Cancer Institute, around 1,685,210 new cases of cancer are likely to be diagnosed in the U.S. in 2016 and about 595,690 people are estimated to die from the disease. Since immunotherapy is used as a first line of treatment in the management of cancer, the market immunotherapy drugs market will grow accordingly. North America is the largest region in the global immunotherapy drugs market and is expected to retain its dominance over the forecast period. Asia Pacific is likely to be the fastest-growing marketover the forecast period. The elevated growth of this region can mainly be attributed to low cost of manufacturing of these drugs in the region, rising occurrence of cancer and favorable regulatory framework in this region.

Some of the companies operating in the immunotherapy drugs market in the current scenario are GlaxoSmithKline, F. Hoffmann-La Roche AG, AbbVie, In., Merck & Co., Inc. Amgen, Inc., Bristol-Myers Squibb, Eli Lilly and Company, Novartis International AG, AstraZeneca plc and Johnson & Johnson. Click To Read More On Immunotherapy Drugs Market

Comments

Post a Comment

Popular posts from this blog

Medical Automation Market Analysis, Growth, Size, Share, Trends, Supply Demand and Forecast to 2026

Medical automation is a technology used to minimize medical errors, promote better management of chronic illness, and to enable healthcare professionals to anticipate prognosis. It controls the diagnostic, monitoring, and therapeutic machineries that serves the major responsive tasks into the hospitals. It also increases the predictability of outcome when patients follow a standardized care path supported by automation. Moreover, automation can help to detect when a patient has deviated from recommended care plan so the care team can intervene. The technology implementation enhances efficiency of hospitals by reducing the process time and improving accuracy of a medical procedures. Medical automation in hospitals such as using robotic assisted systems for health check-ups, is also propelling the growth of the market and in turn improving patient safety. Hospitals are adopting the medical robotics to reduce the HAIs rates in healthcare facility and to provide cleaner and saf...
Read more

Medical Disposables Market to Witness a Pronounce Growth by 2026

Medical disposables are products that are used in hospitals or in various medical fields for prevention of infections and for safety measures to meet the medical standards. The medical disposables are important to lower the risk of cross-contamination and infections that is a primary aim of healthcare professionals and governments globally. Medical disposables includes conventional syringes, disposable medical catheters, isolation gowns, procedure kits and trays, blood glucose tes t strips, and wound care products. The medical disposables are the essential component of every hospital and they have one time usage and need to be disposed after use. Medical disposables are used in surgery, drug and fluid delivery, wound management, diagnostic testing, patient examination, incontinence management, sterilization, and to reduce the discomfort of patient. The need of safety and prevention from infections for the various medical fields such as surgical wear, hygiene, anesthesia and ped...
Read more

Cancer Vaccines Market Taking New Steps to Meet the Challenges With Major Key Companies

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. On the basis of the type of cell it initiates to form cancerous with, it is divided into carcinoma, lymphomas, leukaemias, brain tumors, and sarcomas. According to World Health Organization (WHO), 2017, nearly 1 in 6 deaths is due to cancer globally and around 70% of deaths from cancer occur in low- and middle-income countries. Moreover, it is projected that for next two decades, 70% of new cases are expected to be diagnosed globally. Advent of cancer vaccines can significantly reduce this numbers and lead a cancer-free life for the global population. Key players in the global cancer vaccines market include, Astrazeneca Plc. (Medimmune, LLC.), Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Aduro BioTech Inc., Sanpower Group, Astellas Pharma Inc., CSL Limited, Pfizer Inc., and Serum Institute of India Pvt. Ltd. Dow...
Read more